A lthough chronic kidney disease (CKD) is progressive, most patients die from cardiovascular disease (CVD) before reaching end-stage renal disease.
synthase, thereby redirecting COX-products to vasoconstrictor actions. 16 Indeed, COX-2 generates endoperoxides (PGH 2 ) and TxA 2 that activate TP-Rs in vascular smooth muscle cells that, during increased ROS, mediate an endothelium-dependent contracting factor response. 9, 17 Thus, TP-R signaling can be downstream from increased ROS. Surprisingly, however, genetic deletion of TP-Rs prevented an increased excretion of the oxidative stress marker 8-isoprostane F 2α in mice infused with ANG II. 11 Thus, TP-R signaling also can be upstream of increased ROS. ROS 18 and CKD 19 both increase ET-1 generation. However, the mechanisms interlinking TP-R activation, ROS, and ET-1 generation are unclear. 20 Therefore, we tested the hypothesis that ROS and ET-1 generated in microvessels of mice with RRM depend on COX-2 generation of PGs or TxA 2 that activate TP-Rs. These studies have translational effect because drugs that block TP-Rs are already in clinical trials with promising responses. 21 If they were found to reduce vascular contractility, remodeling, ROS, and ET-1 generation in CKD, they could fill a therapeutic void to prevent CVD, which is now the principal cause of death and disability in these patients.
Methods

Animal Preparation and Surgery
Male C57BL6 mice weighing 25 to 30 g (Charles River Laboratory, Germantown, MD), TP-R knockout (−/−), and TP-R wild-type (TP+/+) mice (C57/BL6J background, kind gift from Thomas Coffman, MD, Duke University, Chapel Hill, NC) were maintained on tap water and standard chow (Na + content 0.4 g/100 g; Harlan Teklad) and allowed free access to tap water. All of the procedures conformed to the Guide for Care and Use of Laboratory Animals by the National Institute of Health for Laboratory Animal Research and were approved by the Georgetown University Animal Care and Use Committee.
A 2-step surgical 5/6 nephrectomy procedure was used to create RRM under inhalational anesthesia with 2% isoflurane and oxygen mixed with room air in a vaporizer. 13, 14 Approximately, two thirds of the mass of the left kidney was ablated by stitching off each pole using an absorbable hemostat (Ethicon, Inc.). At a second surgery 1 week later, the right kidney was removed. SHAM-operated control mice (SHAM) were subjected to a similar 2-stage procedure without the removal of renal mass. Mice were studied after 3 months, at which time they had considerable oxidative stress with a 7-fold increase in excretion of 8-isoprostane F 2α but an unchanged BP and only mild albuminuria, glomerulosclerosis, tubulointerstitial fibrosis, and a 33% reduction in measured overall glomerular filtration rate.
13,14
Measurement of Plasma Endothelin 1 Concentration
Plasma concentrations of ET-1 were measured using a Quantikine ELISA kit (R&D Systems, Minneapolis, MN).
22
Measurement of Urinary 8-Isoprostane F 2α , Thromboxane B 2 , Malondialdehyde, Microalbumin, and Creatinine
Mice were housed in metabolic cages (Nalgene Nunc International, Rochester, NY). Urine was collected for 24 hours into tubes containing antibiotics as described. 23, 24 8-Isoprostane F 2α (Cellbio Labs, Inc., San Diego, CA) and thromboxane B 2 (TxB 2 ; QYAEE-Bio, Shanghai, China) in urine were quantified by ELISA after purification, extraction, and measurement of individual recovery by spiking with radiolabelled PGE 2 , as described and validated previously against gas chromatography/mass spectrometry. 24 Malondialdehyde (MDA) was measured by an assay kit (Cayman Chemical Company, Ann Arbor, MI) 17 and microalbumin by an ELISA kit (Exocell, Philadelphia, PA). Values were normalized with creatinine, which was measured by a urinary creatinine assay kit (Exocell, Philadelphia, PA; see online-only Data Supplement).
Protein Expression of Mesenteric Resistance Arterioles
The expression of ETA-R, p22 phox , p47 phox , COX-1 and -2, and TP-R of mesenteric resistance arterioles were quantified using specific antibodies as described 13, 14, 23, 25, 26 (details see online-only Data Supplement).
RNA Isolation and Real-Time Quantitative RT-PCR
Total RNA isolation and real-time quantitative PCR were performed as previously described with some modifications 27 (details see onlineonly Data Supplement).
Preparation and Study of Mesenteric Resistance Arterioles
Vessels (mean luminal diameter 125±3 ìm and length 2 mm) were separated from the superior mesenteric bed, mounted in a wire Figure S4 ). COX indicates cyclooxygenase; endothelin A-R, endothelin type A receptor; NS, nonsignificant; RRM, reduced renal mass; and TP-R, thromboxane-prosanoid receptor.
by guest on April 30, 2017 http://hyper.ahajournals.org/ Downloaded from myograph (M610, Danish myotechnology A/S; Aarhus, Denmark), and studied as described 28 (see online-only Data Supplement).
Experimental Protocol
The vascular and luminal areas were measured as described. 28, 29 Concentration-response curves to phenylephrine (PE; 10 -8 to 10
-5 mol/L, α-adrenoceptor agonist), U-46,619 (10 -9 to 10 -6 mol/L, TP-R agonist,), and endothelin -1 (ET-1; 10 −10 to 10 −7 mol/L) were compared with vehicle. Because PE-mediated contractions were not enhanced in RRM, ET-1 was selected for further studies.
To examine the functional effects of cellular and mitochondrial ROS, vessels were incubated with vehicle, the membrane permeable redox cycling nitroxide tempol ( 
Endothelin-1-Stimulated Cellular and Mitochondrial ROS in Mesenteric Resistance Arterioles
ET-1 (10 −7 mol/L)-induced cellular and mitochondrial ROS production were determined after loading with dihydroethidium or MitoSox TM Red as described 9, 31 and fluorescence quantified by PTI RatioMaster TM (Photon Technology International, London, Ontario, Canada; see online-only Data Supplement).
Prolonged Effect of TP-Rs in Mice With RRM
RRM or SHAM models were created in TP-R+/+ and TP-R-−/− mice and studied 3 months after the surgery. Plasma ET-1, 24 hour urinary 8-Iso, TxB 2 , MDA, microalbumin, mesenteric arteriolar contractions to PE, ET-1, and U-46,619 and generation of cellular and mitochondrial ROS with ET-1 were obtained as described.
Chemicals and Solutions
Agents were purchased from Sigma (St. Louis, MI) and dissolved in physiological salt solution. 
Statistical Analysis
Data are presented as mean±SEM. Cumulative concentrationresponse experiments were analyzed by nonlinear regression (curve fit) for repeated measurement and differences assessed by 2-way, repeated-measures ANOVA with interaction to assess the effects of RRM versus SHAM, intervention versus vehicle, or TP-R−/− versus TP-R+/+ and the interaction (the effects of the intervention or genotype on the response to RRM). This was followed, if appropriate, with Bonferroni post hoc t-tests for multiple comparisons. A probability value <0.05 was considered statistically significant.
Results
Body, Kidney, and Heart Weights, Mesenteric Resistance Arteriole Remodeling, Plasma
Endothelin-1, and Renal Excretion of Biomarkers
Mice with RRM had normal body, heart, and aorta weights, but despite removal of two-thirds of the left kidney to create RRM, its mass at 3 months exceeded that of SHAM mice, as reported previously (Table 1 ). 14 Mice with RRM had an increased media:lumen ratio of mesenteric resistance arterioles and increased plasma ET-1 and renal excretions of 8-Iso, MDA, TxB 2 , and microalbumin (P<0.05).
Protein Expression in Mesenteric Resistance Arterioles
Vessels from mice with RRM had increased protein expression of ETA-R, p22 phox , COX-2, and TP-R but no significant change in p47 phox or COX-1 (Table 2 ; Figures S1-S3 in the online-only Data Supplement).
Gene Expression in Mesenteric Resistance Arterioles
Vessels from mice with RRM had increased mRNA expression of ETA-R, preproendothelin-1, p22 phox , and COX-2 but no significant change in COX-1 or TP-R (Table 2; Figure S4 ). 
Contractions and ROS Generation With ET-1 in Mesenteric Resistance Arterioles
Vessels from mice with RRM had reduced contractions to PE, but increased contractions to U-46,619 and ET-1 and generated more cellular and mitochondrial ROS with 10 -7 mol/L of ET-1 than SHAM mice ( Figure 1 and Table 3 ).
Effect of Metabolism of Cellular or Mitochondrial ROS or Blockade of COXs, TxA 2 -S, or TP-Rs on Contractions to ET-1 in Mesenteric Resistance Arterioles
The enhanced contractions to ET-1 in vessels from mice with RRM were reduced by incubation with tempol, MitoTEMPO, or paracoxib (a selective COX-2 inhibitor) alone or plus SC-560 (a selective COX-1 inhibitor) or SQ-29,548 (a TP-R inhibitor) but not with SC-560 alone or OKY-046NA (a TxA 2 -S inhibitor; Table 4 ; Figure 2 ).
Effect of TP-Rs in Mice With RRM
Similar to C57/BL6 mice of the prior series, TP+/+ mice with RRM had increased plasma ET-1 and increased excretion of 8-Iso, MDA, TxB 2 , and microalbumin (Table 5) . Their mesenteric resistance arterioles had increased vascular remodeling, decreased contractions to PE, but increased contractions to U-46,619 and ET-1( Figure 3 ) and increased cellular ROS and mitochondrial ROS with ET-1 (Figure 4) . TP-R−/− abolished all of these effects of RRM, except for the reduced PE contractions.
Discussion
We confirm that 3 months of RRM in C57Bl/6 mice increases oxidative stress, albuminuria, and growth of the remaining renal mass. 13, 14 The main new findings are that these mice had increased plasma ET-1 and generated more TxA 2 , their mesenteric resistance arterioles were considerably remodeled and had reduced contractions to PE, but enhanced contractions to U-46,619 and ET-1 and enhanced cellular and mitochondrial ROS with ET-1. The enhanced ET-1 contractions were dependent on cellular and mitochondrial ROS and on TP-Rs and products of COX-2>-1. Unlike TP-R+/+, TP-R−/− mice with RRM did not have significantly enhanced plasma levels of ET-1 or enhanced contractions or cellular or mitochondrial ROS in response to ET-1 and did not have vascular remodeling. Thus, TP-Rs mediate enhanced generation of ET-1 and microvascular ROS and enhanced contractility and remodeling in this mouse model of CKD. Figure 5 presents a schema for the proposed central role for TP-Rs in progressive CKD.
TP-Rs are activated by PGH 2 (a primary product of COX-1 and-2), TxA 2 , and by the stable mimetic, U-46,619. The vascular protein expression of both COX-2 and TP-Rs was upregulated in mice with RRM, and the enhanced responsiveness to ET-1 was dependent on COX-2 and TP-Rs (although blockade of COX-1 with COX-2 was more effective than COX-2 alone, suggesting some adaptive interaction). Because blockade of TxA 2 -S did not prevent enhanced ET-1 contractions, it is likely that PGH 2 , generated by COX-2>COX-1, was the principal PG activating the TP-Rs. Activation of the TP-Rs enhances the generation of PGs and TxA 2 , which further activate the TP-R in a feed-forward manner. 32, 33 This may account for the reduced excretion of TxB 2 in TP-R−/− mice with RRM. Although mice with RRM had increased TP-R protein expression and increased TP-R responses to U-46,619, TP-R mRNA was unchanged. This may relate to oxidative stress that post-transcriptionally prevents TP-R protein degradation and enhances its membrane expression. 34 The enhanced contractions to ET-1 and U-46,619 in vessels from mice with RRM were probably not a consequence of vascular remodeling because contractions to PE were actually diminished. Adrenergic agonists usually do not provoke vascular oxidative stress. 35 Moreover, the structural and functional changes in mice with RRM were likely independent of BP and uremia because prior telemetric measurement of mean arterial pressure were unchanged after 3 months of RRM, and the global glomerular filtration rate was reduced by only 33% 13, 14 ET-1 is generated in vascular endothelial cells. Its production is increased by ROS 18, 36 and CKD. 19 Although ANG II increases ROS in vascular smooth muscle cells largely by activation of NADPH oxidase, 35 ET-1 also activates other source of ROS, including the mitochondria. 37, 38 The present study demostrates that ET-1 activated ethidium:dihydroethiduim fluorescence ratio and mitoSOX TM Red fluorescence, 39 and both tempol (distributed throughout the cell) 40, 41 and mitoTEMPO (partitioned into mitochondria) [39] [40] [41] prevented the enhanced contractility to ET-1 in vessels from mice with RRM. Thus, both sources of ROS were activated in mice with RRM and apparently both contributed to enhanced contractions to ET-1. p22 phox is an essential chaperone protein for neutrophial oxidases. 26, 42 It was strongly upregulated in vessels from mice with RRM and could account for the observed increase in cellular ROS because in vivo silencing of p22 phox prevents the progressive increase in excretion of 8-Iso and the hypertension of rats infused with ANG II. 26 Neutrophil oxidases-2 is expressed in resistance arterioles and the kidney 42 and was upregulated >3-fold in the kidneys of mice with RRM.
14 An uncoupled endothelial NOS may have contributed also to the increased ROS. 43 In contrast to TP-R+/+, TP-R−/− mice with RRM did not have significantly increased plasma levels of ET-1 or excretions of MDA, TxB 2 , or microalbumin or significantly enhanced cellular or mitochondrial ROS or contractions to ET-1 (although there were trends suggesting some residual effects). However, the reduced contractions to PE persisted in TP-R-1−/− mice with RRM, which might represent downregulation of vascular α-adrenoreceptors during enhanced sympathetic nervous activity in RRM. 44 The absence of vascular remodeling in arterioles from TP-R−/− mice with RRM may represent less vascular ROS. 45, 46 Vascular remodeling in mice with ANG II is dependent on TP-Rs in vascular smooth muscle cells. 47 Our findings extend microvascular studies 9 that have reported that ROS enhance TP-R activity and responsiveness to ANG II and ET-1 by demonstrating that this pattern occurs in a model of CKD and that vascular TP-Rs are required to generate cellular and mitochondrial ROS with ET-1. Thus, TP-Rs are both upstream and downstream of ROS and thereby may play essential mediating and reinforcing roles in the generation of ROS from cellular and mitochondrial sources. They could thereby enhance remodeling and contractility of microvessels in CKD. 
Perspective
Future CVD events are predicated by endothelial dysfunction and vascular remodeling, 48, 49 which are frequently accompanied by oxidative stress, 49 as in CKD. 50 ROS, 7, 29, 50 ET-1, 19 and TxA 2 14,51,52 are all increased in patients with CKD. The vascular remodeling, enhanced ROS, and responsiveness to ET-1 and thromboxane in mice with RRM were prevented by genetic deletion of TP-Rs. Thus, TP-R antagonists, which have already been used in clinical trials, 21 could be novel drugs to prevent vascular oxidative stress and CVD in patients with CKD.
ETA-R blockade improves renal function 19 and reduces glomerulosclerosis in a rat model of RRM 53 and markedly reduces albuminuria in patients with diabetic 54 and nondiabetic 55 CKD. Because we now show the importance of TP-Rs in activating the ET-1 system in RRM, TP-R antagonists may reduce renal disease progression in addition to vascular injury. 
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Danvers, MA); TP-receptor (1:1500 dilution, Thermo Scientific, Rockford IL). β-actin antibody was used (1:25000, Sigma-Aldrich, St. Louis, MO) as a control for equal loading of samples. The membranes were exposed to secondary antibodies, diluted to 1:5000 (goat anti-rabbit IgG conjugated with horseradish peroxidase, Pierce no. 31463,) for 1 hour at room temperature. The specific bands were visualized and analyzed densitometrically with a Fuorochem Enhanced Chemiluminescence system (FluorChem E system, ProteinSimple, Santa Clara, CA).
RNA isolation from mesenteric resistance arterioles and real-time quantitative RT-PCR:
Total RNA isolation and real-time quantitative PCR was performed as previously described with some modifications Preparation and study of mesenteric resistance arterioles: Four segments of second-generation branches of mesenteric arteries (about 2 mm in length with an internal diameter of less than 170 m) were mounted on two 40 m stainless steel wires in an isometric four-chamber Mulvany-Halpern myograph (Model M610, Darush Myo Technology A/S, Aarhus, Denmark) 2 . One wire was attached to a force transducer and the other to a micrometer to enable the wall tension to be measured at a predetermined internal circumference. Both the dissection and mounting of the vessels were carried out in cold (4ºC) physiological salt solution (PSS).
Experimental protocol for mesenteric resistance arterioles: Vessels were equilibrated for 30 min in PSS (in mmol·L ) were assessed by cumulative addition to the organ bath. A fluorescence microscope (Olympus IX 71, Olympus, Virginia, USA) equipped with RatioMaster™ spectrofluorometer system (Photo technology International, Canada) was used to evaluate ROS generation, as described previously and below 4 .
Cellular and Mitochondrial ROS of mesenteric resistance arterioles
Dihydroethidium (DHE, Invitogen, Carlsbad, CA) is a cellular ROS indicator that freely permeates into cells. It is oxidized by ROS into the highly fluorescent ethidium (Eth) which is trapped intracellularly and intercalated into DNA. The conversion of DHE to Eth is quantified by a ratiometric method using a dual wavelength determination using an excitation wavelength of 380 nm and an emission wavelength of 460 nm for DHE and an excitation wavelength of 480 nm and an emission wavelength of 605 nm for Eth of endothelin-1 or vehicle were added and the Eth:DHE ratio were assessed at 1 min periods. The changes in ROS after 5 6 minutes of incubation were monitored with a real time photomultiplier that recorded either the ratio of Eth:DHE or mitoSOX fluorescence 6, 7 (Felix32, Photon Technology International, Lawrenceville, NJ). The system utilized an Olympus IX70 fluorescence microscope with ratiomaster fluorescence measurements with a dual photomultiplier system (Photon Technology International, Lawrenceville, NJ). Fluorescent images were captured using an Olympus (Melville, NY) IX71 fluorescent microscope at 20× magnification equipped with a HQ2 CCD cooled camera and further analyzed by Nikon element advance research microscope imaging software.
